TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
VRXA

Veraxa Biotech AG

Healthcare · Biotechnology

1.30$ +15.6% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow VRXA
Line item 2023 2024 2025
– – –
– +1.4% +5.1%
– +140.8% +187.3%
– – +168.9%
– -48.0% +261.7%
– – –
– -85.2% +255.9%
– -240.8% –
– – –

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?